Intra-Cellular Therapies (NASDAQ:ITCI) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of Intra-Cellular Therapies (NASDAQ:ITCI – Free Report) in a research report released on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. Several other analysts have also recently commented on the company. Needham & Company LLC restated a “hold” rating on shares of Intra-Cellular Therapies in a […]
More Stories
US Stocks Roar Back in Roller-Coaster Week, Led by Gold Producers, Big Tech
By Panos Mourdoukoutas U.S. stocks continued their roller-coaster ride this week, driven by rising Treasury bond yields and media headlines...
US Economy Adds Hotter-Than-Expected 228,000 New Jobs in March
By Andrew Moran The U.S. labor market remained robust in March amid market turmoil and growing economic concerns, new data...
When You Fight the Night: 5 Exercises to Help You Conquer Occasional Insomnia
By Kevin Shelley The ceiling fan just isn’t that interesting. I conclude this every time I suffer from insomnia, lying...
Passengers Will Soon Need Real ID to Board Domestic Flights, TSA Warns
By Bill Pan In less than a month, Americans without a star on their driver’s license may face potential delays...
New US Warship Deploys in Support of Border Security Operations
By Ryan Morgan The U.S. Navy has dispatched a warship to help support ongoing U.S. border security operations on April...
Energy Secretary Says US, Saudi Arabia on Pathway to Civil Nuclear Agreement
By Jacob Burg Saudi Arabia and the United States will sign a preliminary agreement of cooperation as the kingdom intends...